Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS and FTD disease models

被引：0
|
作者：
Armakola, M.
Figley, M.
Gitler, A. D.
机构：
来源：
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 50 条
  • [21] TDP43: A Focal Point for RNA Therapeutics in ALS/FTD
    Barmada, Sami
    ANNALS OF NEUROLOGY, 2024, 96 : S300 - S300
  • [22] Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD
    Kumar, Sunny
    Phaneuf, Daniel
    Cordeau, Pierre
    Boutej, Hejer
    Kriz, Jasna
    Julien, Jean-Pierre
    MOLECULAR NEURODEGENERATION, 2021, 16 (01)
  • [23] Loss of aly/ALYREF suppresses toxicity in both tau and TDP-43 models of neurodegeneration
    Kow, Rebecca L.
    Black, Aristide H.
    Saxton, Aleen D.
    Liachko, Nicole F.
    Kraemer, Brian C.
    GEROSCIENCE, 2022, 44 (02) : 747 - 761
  • [24] Loss of aly/ALYREF suppresses toxicity in both tau and TDP-43 models of neurodegeneration
    Rebecca L. Kow
    Aristide H. Black
    Aleen D. Saxton
    Nicole F. Liachko
    Brian C. Kraemer
    GeroScience, 2022, 44 : 747 - 761
  • [25] Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD
    Sunny Kumar
    Daniel Phaneuf
    Pierre Cordeau
    Hejer Boutej
    Jasna Kriz
    Jean-Pierre Julien
    Molecular Neurodegeneration, 16
  • [26] Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS
    Gijselinck, I.
    Sleegers, K.
    Engelborghs, S.
    Robberecht, W.
    Martin, J. -J.
    Vandenberghe, R.
    Sciot, R.
    Dermaut, B.
    Goossens, D.
    van der Zee, J.
    De Pooter, T.
    Del-Favero, J.
    Santens, P.
    De Jonghe, P.
    De Deyn, P. P.
    Van Broeckhoven, C.
    Cruts, M.
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007, 2007, : 1 - 11
  • [27] A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
    Katherine E. Irwin
    Pei Jasin
    Kerstin E. Braunstein
    Irika R. Sinha
    Mark A. Garret
    Kyra D. Bowden
    Koping Chang
    Juan C. Troncoso
    Abhay Moghekar
    Esther S. Oh
    Denitza Raitcheva
    Dan Bartlett
    Timothy Miller
    James D. Berry
    Bryan J. Traynor
    Jonathan P. Ling
    Philip C. Wong
    Nature Medicine, 2024, 30 : 382 - 393
  • [28] Toward the discovery of PET radiotracer for imaging TDP-43 aggregates in FTD and ALS patients
    Boudou, Cedric
    Darmency, Vincent
    Seredenina, Tamara
    Kocher, Jacqueline
    Stoehr, Jan
    Kroth, Heiko
    Purohit, Ajay
    Paterson, David
    Martarello, Laurent
    Pfeifer, Andrea
    Muhs, Andreas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [29] Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
    Arai, Tetsuaki
    Hasegawa, Masato
    Nonoka, Takashi
    Kametani, Fuyuki
    Yamashita, Makiko
    Hosokawa, Masato
    Niizato, Kazuhiro
    Tsuchiya, Kuniaki
    Kobayashi, Zen
    Ikeda, Kenji
    Yoshida, Mari
    Onaya, Mitsumoto
    Fujishiro, Hiroshige
    Akiyama, Haruhiko
    NEUROPATHOLOGY, 2010, 30 (02) : 170 - 181
  • [30] Deletion of Tdp-43 in neurons impairs autophagy and promotes endophenotype of ALS-FTD
    Jeong, Y. H.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 : 26 - 26
12345